Site Editors

Shaji K. Kumar, MD

Prashant Kapoor, MD, FACP

Advertisement
Advertisement

Dana-Farber Receives $40 Million Grant to Support Multiple Myeloma Research

By: JNCCN 360 Staff
Posted: Friday, February 11, 2022

Paula and Rodger Riney of St. Louis, through the Paula and Rodger Riney Foundation, have announced a $40 million grant to support multiple myeloma research at the Dana-Farber Cancer Institute. The grant represents the largest single award supporting multiple myeloma research in Dana-Farber’s history. The Paula and Rodger Riney Foundation has cumulatively donated nearly $60 million to the Institute. 

“The path to developing new treatments for multiple myeloma is through rigorous research. The most effective way to spur that research is in supporting the scientists doing the complex work. The Riney Family are generous and stalwart supporters, and through this grant and their previous support, they continue to make a profound impact on scientific discovery and clinical care. Their leadership will help patients at Dana-Farber and around the world,” said Laurie H. Glimcher, MD, President and Chief Executive Officer of Dana-Farber and the Richard and Susan Smith Professor of Medicine at Harvard Medical School.

This new $40 million grant will specifically focus on the following three goals:

  • To renew support for preclinical experiments to identify novel targets and develop new medicines and immune-based therapies for patients
  • To fund clinical research designed to test novel myeloma therapies, alone and in combination with standard and experimental treatments, to improve patient outcomes
  • To support and co-locate myeloma labs at Dana-Farber to facilitate greater cohesion and collaboration among members of the research team.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.